Geron (GERN)
Markets RYTELO, the only approved telomerase inhibitor, for transfusion-dependent low-risk MDS patients.
$1.25
vs last close−0.06 (−4.96%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 74.57% | 479.08M shares | |
|---|---|---|---|
| 267 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.06% | 385.9K shares | |
| 7 holders · as of Jul 1, 2026 | |||
| Other | ≈ 25.37% | 163.00M shares | |
| remainder | |||
642.47M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
267 holders · 479.08M shares · 38 new positions · 133 increased · 65 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 49.12M | 7.64% | +1.80M | Aug 7, 2026 |
| Ra Capital Management, L.P. | 42.81M | 6.66% | −20.96M | Aug 14, 2026 |
| Soleus Capital Management, L.P. | 42.81M | 6.66% | +1.30M | Aug 11, 2026 |
| State Street Corp | 35.86M | 5.58% | +5.36M | Aug 7, 2026 |
| Citadel Advisors LLC | 29.04M | 4.52% | +7.46M | Sep 2, 2026 |
| Vanguard Capital Management LLC | 27.25M | 4.24% | +581.2K | Aug 13, 2026 |
| Clearbridge Investments, LLC | 19.65M | 3.06% | +28.5K | Aug 13, 2026 |
| Eversept Partners, LP | 18.72M | 2.91% | −117.5K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RA Capital Management, L.P. | 9.90% | 63.99M | 13G | May 15, 2025 |
| Roderick Wong, M.D.incl. RTW Investments, LP | 7.30% | 44.11M | 13G | Nov 14, 2024 |
| Soleus Capital Master Fund, L.P. | 6.50% | 41.51M | 13G | May 8, 2026 |
| State Street Corporation | 5.60% | 35.86M | 13G | Aug 7, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 18, 2026 | Michelle Robertsonofficer: EVP, CHIEF FINANCIAL OFFICER | Sale | 9,855 | $1.94 | 17,645 |
House and Senate disclosures
Not reported.